Literature DB >> 3096127

Coronary thrombolysis in patients with acute myocardial infarction by intravenous infusion of synergic thrombolytic agents.

D Collen, D C Stump, F Van de Werf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3096127     DOI： 10.1016/0002-8703(86)90323-6

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  8 in total

Review 1.  New thrombolytic strategy: bolus administration of tPA and urokinase-fibrinogen conjugate.

Authors:  A V Maksimenko; E G Tischenko
Journal:  J Thromb Thrombolysis       Date:  1999-06       Impact factor: 2.300

2.  Is thrombolysis alone the best therapy for acute myocardial infarction? Current status and emerging strategies.

Authors:  P Golino; J T Willerson
Journal:  Tex Heart Inst J       Date:  1991

Review 3.  Thrombolysis. An approach still on the move.

Authors:  M Verstraete
Journal:  Drugs       Date:  1989-02       Impact factor: 9.546

4.  Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.

Authors:  R Pannell; J Black; V Gurewich
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

Review 5.  [Antibody mediated thrombolysis. A new therapeutic principle].

Authors:  C Bode; W Kübler
Journal:  Klin Wochenschr       Date:  1989-07-03

Review 6.  Drug interactions with thrombolytic agents. Current perspectives.

Authors:  A de Boer; J M van Griensven
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

Review 7.  New strategies in the development of thrombolytic agents.

Authors:  H R Lijnen; D Collen
Journal:  Blut       Date:  1988-10

Review 8.  Recombinant tissue plasminogen activator: a brief review.

Authors:  E B Grossbard
Journal:  Pharm Res       Date:  1987-10       Impact factor: 4.200
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.